Information:
Fel:
Nyckelord
Low-Grade Lymphoma ×
- Clinical Trial (123)
- Hematology (62)
- Eligibility Determination (38)
- Registries (30)
- Laboratories (22)
- Radioimmunotherapy (21)
- Medical Oncology (18)
- On-Study Form (17)
- Disease Response (15)
- Physical Examination (12)
- Follow-Up Studies (12)
- Antibodies (10)
- Lymphoma, B-Cell (5)
- Chemotherapy, Adjuvant (4)
- Positron-Emission Tomography (4)
- Adverse event (4)
- Treatment Form (4)
- Iodine (4)
- Medical History Taking (4)
- Neoplasm Staging (4)
- Radiology (3)
- Survival (3)
- Baseline (3)
- Concomitant Medication (3)
- Off-Treatment (3)
- Drug Therapy (3)
- Infection (3)
- Infusions, Intravenous (3)
- Lymphoma (3)
- Pathology (3)
- Gamma Cameras (2)
- Lymphoma, Large B-Cell, Diffuse (2)
- Biopsy (2)
- Clinical Chemistry Tests (2)
- Consensus (2)
- Registration (2)
- Disease Status (2)
- Scores & Instruments (2)
- Death (2)
- HIV (2)
- Hodgkin Disease (2)
- Lymph Nodes (2)
- Neoplasms (2)
- Prostatic Neoplasms (1)
- Questionnaires (1)
- Radiation (1)
- Radiation Dosage (1)
- Therapeutics (1)
- Whole-Body Irradiation (1)
- Colorectal Neoplasms (1)
- Comorbidity (1)
- Comment (1)
- Endometrial Neoplasms (1)
- Clinical Trial, Phase III (1)
- Blood Transfusion (1)
- Toxicity Tests (1)
- Cancer Vaccines (1)
- Breast Neoplasms (1)
- Lymphoma, Mantle-Cell (1)
- Burkitt Lymphoma (1)
- Chemoradiotherapy (1)
- End of Study (1)
- Classification (1)
- Death Certificates (1)
- Demography (1)
- Diagnostic Imaging (1)
- Dosage Forms (1)
- Lung Neoplasms (1)
- Lymphoma, Follicular (1)
- Melanoma (1)
- Anti-Infective Agents (1)
- Antibodies, Monoclonal (1)
- Ovarian Neoplasms (1)
- Patient Admission (1)
Innehållsförteckning
Valda datamodeller
Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.
180 Sökresultat.
Item-grupper: Comorbidity, Discontinuation, Adverse event, Footer module
Item-grupper: CRF Header, Lymphoma: Form Administration, Non-Hodgkin's Lymphoma: Disease Description, Non-Hodgkin's Lymphoma: Baseline Hematology/Chemistry, Lymphoma: Prior Treatment, Lymphoma: Relapsed Disease
Item-grupp: Patient Information
Item-grupper: Header Module, HIV History, History of Malignancy for study, HIstory of Other Malignancy, Antiretroviral Therapy, Comments
Item-grupper: Header, HIV History, History of Malignancy for study, HIstory of Other Malignancy, Antiretroviral Therapy, Comments
Item-grupper: Header Module, HIV History, History of Malignancy for study, HIstory of Other Malignancy, Antiretroviral Therapy, Comments
Item-grupper: Patient demographics, Staging, Lab results, Nodal involvement, Extranodal involvement, Overall result, Dscontinuation of therapy, IPI, Footer module
Item-grupper: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
Item-grupper: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
Item-grupper: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Hematopoietic Regeneration, Intercurrent disease, Footer module
Item-grupper: Patient demographics, Therapy, Chemotherapy Regimen, Intrathecal therapy, Supportive therapy, Administration of medication, Comorbidity at the therapy begin, Medication duration, G-CSF, Cycle duration, Therapy discontinuation, Stem Cell Mobilization, Lab results prior to chemotherapy cycle, Lab results during interval after chemotherapy cycle, Toxicity, Intercurrent disease, Footer module
Item-grupper: PET investigation basic documentation, Extent of examination, Set up equipment, Nodal involvement, Pet result, Footer module